top of page

Free Biopharma Daily Stock Updates - 06/25/21

$XBI $138.7 +1.0%


Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!


Pipeline Updates

$LXRX +18.7% Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Association 81st Scientific Sessions. source

$MDGL -0.3% Madrigal Pharmaceuticals Announces Presentation of Positive Clinical Data of Resmetirom from Open-Label Portion of Ongoing Phase 3 Clinical Trial MAESTRO-NAFLD-1 at The International Liver Congress™ 2021. source

$AUPH -1.0% Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA) source

$PIRS -8.5% Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Dollar Grant From Bavarian Government To Accelerate Program Development for Post-COVID-19 Pulmonary Fibrosis source

$DYN 0.4% Dyne Therapeutics Presents Preclinical Data from its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress source

$ARWR +0.9% Arrowhead Presents Preclinical Data on ARO-DUX4 at FSHD Society International Research Congress source

$JAZZ +1.3% Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution source

$IMAB -4.0% I-Mab Announces China NMPA Approval for Phase 1b Trial of Felzartamab in Systemic Lupus Erythematosus source

$VERU -0.4% Veru Enrolls First Patient in Phase 3 VERACITY Clinical Trial of Sabizabulin (VERU-111) in Metastatic Castration Resistant and Androgen Receptor Targeting Agent Resistant Prostate Cancer source

$VIR -8.2% Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021 source

$FGEN -4.9% Astellas Receives Positive CHMP Opinion for EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease source

Financial Updates

$OSMT +33.1% Osmotica Pharmaceuticals plc Announces Conclusion of Strategic Process with Agreement for the Sale of Legacy Business to Alora Pharmaceuticals, LLC. source

$RVVTF +1.2% Revive Therapeutics Approved to Trade on the OTCQB Market. source

$GNFT +1.1% GENFIT obtains non-dilutive financing of €11 million in the form of a State Guaranteed Loan source

$AVXL -0.8% Anavex Life Sciences Announces Closing of $50 Million Registered Direct Offering source

$TBPH -8.8% Theravance Biopharma, Inc. Announces Proposed Public Offering of Ordinary Shares source


Posted by FS



bottom of page